Galal-Khallaf, A.; Mousa, D.; Atyah, A.; El-Bahnsawye, M.; Hussein, M.K.A.; El Sayed, I.E.T.; Elmongy, E.I.; Binsuwaidan, R.; El-Torgoman, A.M.A.K.; Abdel-Bary, H.;
et al. In Vivo Antidiabetic and Antilipidemic Effect of Thiazolidine-2,4-Dione Linked Heterocyclic Scaffolds in Obesity-Induced Zebrafish Model. Pharmaceuticals 2025, 18, 1023.
https://doi.org/10.3390/ph18071023
AMA Style
Galal-Khallaf A, Mousa D, Atyah A, El-Bahnsawye M, Hussein MKA, El Sayed IET, Elmongy EI, Binsuwaidan R, El-Torgoman AMAK, Abdel-Bary H,
et al. In Vivo Antidiabetic and Antilipidemic Effect of Thiazolidine-2,4-Dione Linked Heterocyclic Scaffolds in Obesity-Induced Zebrafish Model. Pharmaceuticals. 2025; 18(7):1023.
https://doi.org/10.3390/ph18071023
Chicago/Turabian Style
Galal-Khallaf, Asmaa, Dawlat Mousa, Aml Atyah, Mohamed El-Bahnsawye, Mona K. Abo Hussein, Ibrahim El Tantawy El Sayed, Elshaymaa I. Elmongy, Reem Binsuwaidan, Abdel Moneim A. K. El-Torgoman, Hamed Abdel-Bary,
and et al. 2025. "In Vivo Antidiabetic and Antilipidemic Effect of Thiazolidine-2,4-Dione Linked Heterocyclic Scaffolds in Obesity-Induced Zebrafish Model" Pharmaceuticals 18, no. 7: 1023.
https://doi.org/10.3390/ph18071023
APA Style
Galal-Khallaf, A., Mousa, D., Atyah, A., El-Bahnsawye, M., Hussein, M. K. A., El Sayed, I. E. T., Elmongy, E. I., Binsuwaidan, R., El-Torgoman, A. M. A. K., Abdel-Bary, H., & Mohammed-Geba, K.
(2025). In Vivo Antidiabetic and Antilipidemic Effect of Thiazolidine-2,4-Dione Linked Heterocyclic Scaffolds in Obesity-Induced Zebrafish Model. Pharmaceuticals, 18(7), 1023.
https://doi.org/10.3390/ph18071023
